PsyPost on MSN

Recreational ecstasy use is linked to lasting memory impairments

Use of the drug MDMA, commonly known as ecstasy, may lead to lasting difficulties with learning and memory that persist long after a person stops taking it. A new analysis indicates that people who ...
ABC News

FDA advisers vote against recommending approval of MDMA as treatment for PTSD

The independent panel casted doubt on MDMA being a safe and effective treatment. A panel of independent advisers for the U.S. Food and Drug Administration voted against recommending approval of ...
European Medical Journal

MDMA-Assisted Therapy Shows Sustained Benefits in Depression

MDMA-assisted therapy may provide lasting benefit for patients with MDD. Seven-month follow-up shows sustained symptom ...
Yahoo

Advocates of MDMA-Assisted Psychotherapy Complain that 'the FDA Moved the Goalposts'

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...
MedPage Today

FDA Staff Questions Safety of MDMA Treatment for PTSD

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FDA staff raised ...
Reason

FDA Advisers Overwhelmingly Oppose Approval of MDMA As a Psychotherapeutic Catalyst

Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock on Tuesday when an expert panel overwhelmingly voted to recommend that the Food and Drug Administration ...
NBC New York

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to ...
USA Today

FDA panel rejects first MDMA-based PTSD treatment

A panel of advisers to the U.S. health regulator on Tuesday voted against a therapy based on the party drug MDMA for patients with post-traumatic stress disorder, in a major setback to the nascent ...
Inverse

MDMA’s Future As A Treatment For PTSD Is In Question

On Tuesday, an expert panel advising the Food and Drug Administration (FDA) on the use of MDMA, or ecstasy, in combination with talk therapy to treat post-traumatic stress disorder rejected the ...
The Hill

FDA’s MDMA rejection delays PTSD treatment options

The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.
Seeking Alpha

MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors

Mind Medicine (MindMed) Inc. (MNMD) is a biotech that should be on everyone's watch list. The reason why I state this is that it has been able to make substantial improvements in the MDMA treatment ...